| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $91.9M | +59.2% |
| SG&A Expense | $40.2M | +37.9% |
| Operating Income | $144.6M | +312.9% |
| Pre-tax Income | $151.3M | +324.2% |
| Income Tax | $42.1M | — |
| Net Income | $111.2M | +269.6% |
| EPS (Basic) | $2.46 | +261.8% |
| EPS (Diluted) | $2.38 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $156.2M | +161.2% |
| Short-term Investments | $311.1M | +34.9% |
| Current Assets | $474.5M | +60.0% |
| Total Assets | $561.1M | +28.3% |
| Current Liabilities | $22.5M | +91.5% |
| Total Liabilities | $26.1M | +120.9% |
| Stockholders' Equity | $535.0M | +25.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$126.7M | -191.6% |
| Capital Expenditures | $1.1M | — |
| Investing Cash Flow | $249.0M | +174.6% |
| Financing Cash Flow | -$25.9M | -109.6% |
| Free Cash Flow | -$127.8M | -194.2% |
| +256.6% |